Our company began releasing the FLD HbA1c from the SFM App Store at the end of September 2025. From the end of October 2025, we initiated international releases and are currently distributing in 18 countries, including Japan.
We are pleased to announce the upcoming launch of the ‘FLD SpO2,’ which is capable of estimating oxygen saturation and pulse rate. Similar to the FLD HbA1c, the ‘FLD SpO2’ is completely non-contact and non-invasive, allowing measurements to be taken in a short period (approximately 10 seconds).
Details regarding the release are as follows:
Release Date: December 17, 2025（JP Time）
Price: Japan – 200 JPY per month (excluding tax)
Overseas – 1.50 USD per month (excluding tax)
Target Countries:
- Japan
- Vietnam
- Thailand
- Cambodia
- Indonesia
- Laos
- Philippines
- Malaysia
- Bhutan
- Bangladesh
- Pakistan
- Mongolia
- Uzbekistan
- Tajikistan
- Kyrgyzstan
- Mexico
- Brazil
- New Zealand
- Australia
Australia has been added this time, bringing the total number of countries for the release to 19（Australia release FLD SpO2 only）.
Further details regarding additional releases will be announced in due course through press releases.
*Please note that our products are not medical devices as defined by the Pharmaceutical Affairs Law and cannot be used for medical diagnosis. Therefore, they are not a substitute for medical or professional judgment. If you have concerns about your health or notice any changes in your condition, please consult a qualified healthcare professional. Moreover, there are restrictions on compatible devices. Please verify whether your device is supported, and refer to the terms of use and privacy policy before use.*